Buy, Sell or Hold MSTR as Bitcoin Sale Sparks Debate
MicroStrategy sold 32 Bitcoin for about $2.5 million, the company’s first crypto cash-out since 2022. With Bitcoin ar...
Price weighting can skew an index toward higher-priced stocks. This explanation covers implications for interpretation and strategy.
26,532 articlesMicroStrategy sold 32 Bitcoin for about $2.5 million, the company’s first crypto cash-out since 2022. With Bitcoin ar...
Regulators are pressing for clearer access and safer custody as major venues reshape how crypto trades are executed. ...
Lee’s Bitmine moved to grow its ETH treasury with a $41 million purchase, signaling a continued expansion strategy ev...
Fresh inflows into ripple (xrp) funds continue despite a broad downturn in crypto ETFs. XRP price remains around $1.1...
Despite a chorus of buy ratings on Shopify, a dissenting view flags limited upside as AI tools and monetization effor...
Grayscale Research outlines a bull case for AAVE, arguing regulatory clarity could push its fair value toward $175 wi...
The next decade could test Detroit's big automakers as profits shift from rugged trucks to electric and software-led ...
A wave of fresh research notes on Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesfo...
A bold bid to stockpile digital assets for national risk management runs into legal and cross-border hurdles, drawing...
As tax rules permanently allow full deductions for qualifying property in the year of service, corporate buyers are e...
Whale purchases surge, a technical buy signal reappears, and exchange balances retreat as XRP eyes a potential breako...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...